Skip to main content

Animations

MJFF Publications

4061 - 4070 of 6467 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBA
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28472
    Citation Count: 76
  • Summary Details
    OPEN
    Title: Changes in Body Composition Before and After Parkinson's Disease Diagnosis
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28536
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Reply to: “Cell Therapy for Huntington's Disease: Learning from Failure”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28500
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.28534
    Citation Count: 114
  • Summary Details
    OPEN
    Title: Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles
    Journal Name: Cytotherapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jcyt.2021.01.001
    Citation Count: 247
  • A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding
    2021
    Summary Details
    OPEN
    Title: A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding
    Journal Name: Journal of Molecular Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jmb.2021.167323
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for Parkinson disease
    Journal Name: Interdisciplinary Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.inat.2021.101224
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Influence of Age on Magnitude and Timing of Vasodepression and Cardioinhibition in Tilt-Induced Vasovagal Syncope
    Journal Name: JACC: Clinical Electrophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.jacep.2022.05.009
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Comparison of manual and automated measures of walking speed: Distance and pace matter
    Journal Name: Experimental Gerontology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.exger.2022.111987
    Citation Count: 6
  • Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways
    2021
    Summary Details
    OPEN
    Title: Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways
    Journal Name: Free Radical Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.freeradbiomed.2021.08.230
    Citation Count: 23
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.